Internal Medicine Doctors in Blackfoot, ID Accepting Medicare

6 Internal Medicine doctors found. Showing 1 - 6

Mr. Mark Lupton, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 E Alice St, Blackfoot, ID 83221 Phone: 208-785-1200

Mr. Lance Ronald Wehrle, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 98 Poplar St, Blackfoot, ID 83221 Phone: 208-785-3838    Fax: 208-782-3994

Dr. Francis T Johansen, D.O. Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 1441 Parkway Dr, Blackfoot, ID 83221 Phone: 208-785-2600

Mr. Angelo Michael Capricchione, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 98 Poplar St, Blackfoot, ID 83221 Phone: 208-785-3865    Fax: 208-785-3504

Heather Rochelle Curtis, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 98 Poplar St, Blackfoot, ID 83221 Phone: 208-785-4100

Dr. Christopher G Gibson, DO Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 98 Poplar St, Ste. Rheumatology, Blackfoot, ID 83221 Phone: 208-782-3990    Fax: 208-782-3994

News Archive

PA Department of Aging awarded grant to enhance volunteer programs

The Pennsylvania Department of Aging has received a Performance Improvement and Innovation grant from the U.S. Department of Health and Human Services' Administration for Community Living. The grant of $200,000 will be devoted to assist local APPRISE programs in developing strategic approaches to enhance volunteer programs.

Researchers make significant step in understanding and imaging protein synthesis

Researchers at Columbia University, in collaboration with biologists in Baylor College of Medicine, have made a significant step in understanding and imaging protein synthesis, pinpointing exactly where and when cells produce new proteins.

UC Davis researchers awarded $15.5 million to develop world's first total-body PET scanner

A UC Davis research team has been awarded $15.5 million to build the world's first total-body positron emission tomography (PET) scanner, which could fundamentally change the way cancers are tracked and treated and put the university on the nation's leading edge of molecular imaging.

Genome studies may help target new drugs to fight them

One parasite causes a deadly sleeping sickness in Africa. The second damages the internal organs of millions of Latin Americans. The third causes terrible lesions on the face or limbs of victims from Brazil to India.

Phase III clinical trial results of XIAFLEX published in a journal

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products today announced results of the pivotal CORD I Phase III clinical trial of XIAFLEX (collagenase clostridium histolyticum), a novel, first-in-class biologic for the nonsurgical treatment of Dupuytren's disease, was published in today's edition of the New England Journal of Medicine.

Read more Medical News

› Verified 5 days ago